AMFI - Registered Mutual Fund Distributor

Sudeep Pharma Limited IPO

Sudeep Pharma Limited IPO

₹ 14825 / 25 Shares Shares
Minimum Investment

Sudeep Pharma Limited IPO

Issues Price

₹563-593 per equity share

Sudeep Pharma Limited IPO

Open Date

21 Nov 2025

Close Date

25 Nov 2025

Lot Size

25

Min. Investment

₹ 14825

Issue Price

₹563-593

Listing Date

28 Nov 2025

Issues Size

1,50,92,750 shares(aggregating up to ₹895 crore)

Face Value

₹1 Per Equity Share

Total Shares Offered

25 Shares

Offered To Public

25 Shares

Sudeep Pharma Limited IPO

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.It has six manufacturing facilities that have a combined production capacity of 50,000 MT, manufacturing minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. The company supplies over 200 products to a wide customer base across the pharma, food, and nutrition sectors.The company has strong R&D capabilities comprising in-house labs and pilot-scale facilities for mineral salts and excipients. Product Portfolio: Pharmaceutical, Food and Nutrition Business Specialty Ingredients Business Triturates As of 31 December 2024, the company had 704 permanent employees.

Founded In

1989

Managing Director

Sujit Jaysukh Bhayani

Parent Organization

Sudeep Pharma Limited IPO

Application for Sudeep Pharma Limited IPO

Apply as Price Range Apply Upto
Retail (min) ₹563-593 ₹14,825
Retail(max) ₹563-593 ₹1,92,725
SHNI(min) ₹563-593 ₹2,07,550
SHNI(max) ₹563-593 ₹9,93,275
BHNI(min) ₹563-593 ₹10,08,100

Apply for all eligible candidates, Sudeep Pharma Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (6632 Reviews)

KSquare’s platform helped me diversify and start SIPs in mutual funds that really suit my lifestyle. I love how easy and intuitive everything feels.

Charu Ahuja

Charu Ahuja

Event Producer

KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.

Lara Dhamija

Lara Dhamija

Content Editor

KSquare’s guidance was top-tier. I felt informed and in control during the entire loan process. Truly reliable.

Meenal Shah

Meenal Shah

Content Manager

Quick approvals, low documentation, and expert help—KSquare’s loan service is ideal for anyone needing funds quickly.

Priyanka Seth

Priyanka Seth

Fashion Designer

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

KSquare’s mutual fund platform is exactly what I needed. It’s intuitive, offers diverse funds, and gives great insights. I’ve seen real growth since I started.

Naveen Thakur

Naveen Thakur

Risk Analyst

KSquare helped me reconnect financially with India. Their NRI services are intuitive, quick, and focused on individual needs. Truly impressed!

Anjali Deshmukh

Anjali Deshmukh

Architect

I never explored NFOs until KSquare simplified the process. Their breakdown of fund objectives helped me make confident decisions as a first-time investor.

Meera Sood

Meera Sood

Interior Decorator

I highly recommend KSquare for any NRI investor. Their support was proactive and always ensured I felt secure with every transaction.

Arjun Mehra

Arjun Mehra

Cybersecurity Expert

KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.

Pooja Ramesh

Pooja Ramesh

Research Scientist

FAQ's

Frequenlty Asked Question

How do I choose the right asset allocation in NPS?

KSquare helps you select between Active and Auto choices based on your age, risk appetite, and retirement goals.

Is it legal for NRIs to invest in Indian markets via KSquare?

Absolutely. KSquare complies with all SEBI and RBI guidelines, ensuring legal and secure investments for NRIs.

Why should I choose KSquare for my SIP needs?

KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.

What is a Loan Against Mutual Fund (LAMF)?

A Loan Against Mutual Fund allows you to borrow money by pledging your mutual fund units as collateral without selling your investments.

Can I plan for a home or car purchase through SIP?

Absolutely, SIPs help accumulate funds steadily over time so major purchases like home or car become financially stress-free.

What documents are needed for applying LAMF?

Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.

How do I track the performance of an NFO after investment?

Once listed, KSquare provides regular updates and performance tracking via your investor dashboard.

Can I increase my SIP amount later?

Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.